Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis.

Tonelli M, Hemmelgarn B, Reiman T, Manns B, Reaume MN, Lloyd A, Wiebe N, Klarenbach S.

CMAJ. 2009 May 26;180(11):E62-71. doi: 10.1503/cmaj.090470. Review. Erratum in: CMAJ. 2009 Jul 7;181(1-2):61.

2.

The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents.

Mhaskar R, Wao H, Miladinovic B, Kumar A, Djulbegovic B.

Cochrane Database Syst Rev. 2016 Feb 4;2:CD009624. doi: 10.1002/14651858.CD009624.pub2. Review.

PMID:
26845108
3.

Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data.

Bohlius J, Tonia T, Nüesch E, Jüni P, Fey MF, Egger M, Bernhard J.

Br J Cancer. 2014 Jul 8;111(1):33-45. doi: 10.1038/bjc.2014.171. Review.

4.

Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis.

Martí-Carvajal AJ, Agreda-Pérez LH, Solà I, Simancas-Racines D.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD000332. doi: 10.1002/14651858.CD000332.pub3. Review.

PMID:
23450527
5.

Erythropoietin or darbepoetin for patients with cancer.

Tonia T, Mettler A, Robert N, Schwarzer G, Seidenfeld J, Weingart O, Hyde C, Engert A, Bohlius J.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD003407. doi: 10.1002/14651858.CD003407.pub5. Review.

PMID:
23235597
6.

A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.

Wilson J, Yao GL, Raftery J, Bohlius J, Brunskill S, Sandercock J, Bayliss S, Moss P, Stanworth S, Hyde C.

Health Technol Assess. 2007 Apr;11(13):1-202, iii-iv. Review.

7.

Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: study-level and patient-level meta-analyses.

Vansteenkiste J, Glaspy J, Henry D, Ludwig H, Pirker R, Tomita D, Collins H, Crawford J.

Lung Cancer. 2012 Jun;76(3):478-85. doi: 10.1016/j.lungcan.2011.12.015.

8.

Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.

Palmer SC, Saglimbene V, Mavridis D, Salanti G, Craig JC, Tonelli M, Wiebe N, Strippoli GF.

Cochrane Database Syst Rev. 2014 Dec 8;(12):CD010590. doi: 10.1002/14651858.CD010590.pub2. Review.

PMID:
25486075
9.

Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data.

Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfeld J, Zwahlen M, Clarke MJ, Weingart O, Kluge S, Piper M, Napoli M, Rades D, Steensma D, Djulbegovic B, Fey MF, Ray-Coquard I, Moebus V, Thomas G, Untch M, Schumacher M, Egger M, Engert A.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007303. doi: 10.1002/14651858.CD007303.pub2. Review.

PMID:
19588423
10.

Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials.

Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfeld J, Zwahlen M, Clarke M, Weingart O, Kluge S, Piper M, Rades D, Steensma DP, Djulbegovic B, Fey MF, Ray-Coquard I, Machtay M, Moebus V, Thomas G, Untch M, Schumacher M, Egger M, Engert A.

Lancet. 2009 May 2;373(9674):1532-42. doi: 10.1016/S0140-6736(09)60502-X. Erratum in: Lancet. 2009 Jul 4-2009 Jul 10;374(9683):28.

PMID:
19410717
11.

Patterns of use and risks associated with erythropoiesis-stimulating agents among Medicare patients with cancer.

Hershman DL, Buono DL, Malin J, McBride R, Tsai WY, Neugut AI.

J Natl Cancer Inst. 2009 Dec 2;101(23):1633-41. doi: 10.1093/jnci/djp387. Erratum in: J Natl Cancer Inst. 2010 Feb 24;102(4):282-3.

12.

Erythropoiesis-stimulating agents in gynecological malignancies: A study-level meta-analysis.

Marchetti C, De Felice F, Palaia I, Musio D, Muzii L, Tombolini V, Benedetti Panici P.

Crit Rev Oncol Hematol. 2016 Mar;99:123-8. doi: 10.1016/j.critrevonc.2015.12.013. Review.

PMID:
26748593
13.

[Treatment of chemotherapy-induced anemia].

Kadokura G, Katsumata N.

Gan To Kagaku Ryoho. 2014 Apr;41(4):416-20. Japanese.

PMID:
24743356
14.

The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model.

Crathorne L, Huxley N, Haasova M, Snowsill T, Jones-Hughes T, Hoyle M, Briscoe S, Coelho H, Long L, Medina-Lara A, Mujica-Mota R, Napier M, Hyde C.

Health Technol Assess. 2016 Feb;20(13):1-588, v-vi. doi: 10.3310/hta20130. Review.

15.

Erythropoiesis-stimulating agents (ESAs): do they still have a role in chemotherapy-induced anemia (CIA)?

Bormanis J, Quirt I, Chang J, Kouroukis CT, MacDonald D, Melosky B, Verma S, Couture F.

Crit Rev Oncol Hematol. 2013 Aug;87(2):132-9. doi: 10.1016/j.critrevonc.2012.12.010. Review.

PMID:
23357249
16.

Chemotherapy for advanced non-small cell lung cancer in the elderly population.

Santos FN, de Castria TB, Cruz MR, Riera R.

Cochrane Database Syst Rev. 2015 Oct 20;(10):CD010463. doi: 10.1002/14651858.CD010463.pub2. Review.

PMID:
26482542
17.

Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: a systematic review of the literature.

Ross SD, Allen IE, Henry DH, Seaman C, Sercus B, Goodnough LT.

Clin Ther. 2006 Jun;28(6):801-31. Review. Erratum in: Clin Ther. 2007 May;29(5):985-6.

PMID:
16860166
18.

Addition of iron to erythropoiesis-stimulating agents in cancer patients: a meta-analysis of randomized trials.

Petrelli F, Borgonovo K, Cabiddu M, Lonati V, Barni S.

J Cancer Res Clin Oncol. 2012 Feb;138(2):179-87. doi: 10.1007/s00432-011-1072-3. Review.

PMID:
21972052
19.

Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.

Estcourt LJ, Stanworth S, Doree C, Trivella M, Hopewell S, Blanco P, Murphy MF.

Cochrane Database Syst Rev. 2015 Oct 27;(10):CD010984. doi: 10.1002/14651858.CD010984.pub2. Review.

20.

Iron therapy in anaemic adults without chronic kidney disease.

Gurusamy KS, Nagendran M, Broadhurst JF, Anker SD, Richards T.

Cochrane Database Syst Rev. 2014 Dec 31;(12):CD010640. doi: 10.1002/14651858.CD010640.pub2. Review.

PMID:
25550190
Items per page

Supplemental Content

Support Center